Magellan Diagnostics Inc, North Billerica, Mass, has received FDA 510(k) clearance to market the LeadCare Plus blood lead testing system in the United States for the quantification of lead levels in blood. Developed to enhance accessibility to blood lead testing, the single-channel system performs lead analysis in a compact footprint suited for space-constrained labs and clinics. Weighing approximately 3 pounds, the system requires a sample volume of 50 ?l of capillary or venous whole blood. Detection relies on the anodic stripping voltammetry electrochemical technique and takes 3 minutes. Designated as moderately complex, the test system is not intended for point-of-care use but rather for prescription use only. Magellan Diagnostics recommends that a minimum of two levels of quality control be performed each day or shift, before patient samples are tested. For more information, visit Magellan Diagnostics.